Mechanism of hard-nanomaterial clearance by the liver
Top Cited Papers
Open Access
- 15 August 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Materials
- Vol. 15 (11), 1212-1221
- https://doi.org/10.1038/nmat4718
Abstract
The liver and spleen are major biological barriers to translating nanomedicines because they sequester the majority of administered nanomaterials and prevent delivery to diseased tissue. Here we examined the blood clearance mechanism of administered hard nanomaterials in relation to blood flow dynamics, organ microarchitecture and cellular phenotype. We found that nanomaterial velocity reduces 1,000-fold as they enter and traverse the liver, leading to 7.5 times more nanomaterial interaction with hepatic cells relative to peripheral cells. In the liver, Kupffer cells (84.8 ± 6.4%), hepatic B cells (81.5 ± 9.3%) and liver sinusoidal endothelial cells (64.6 ± 13.7%) interacted with administered PEGylated quantum dots, but splenic macrophages took up less material (25.4 ± 10.1%) due to differences in phenotype. The uptake patterns were similar for two other nanomaterial types and five different surface chemistries. Potential new strategies to overcome off-target nanomaterial accumulation may involve manipulating intra-organ flow dynamics and modulating the cellular phenotype to alter hepatic cell interactions.Keywords
This publication has 48 references indexed in Scilit:
- Nanoparticle clearance is governed by Th1/Th2 immunity and strain backgroundJCI Insight, 2013
- A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dotsNature Nanotechnology, 2012
- Pivotal Advance: Characterization of mouse liver phagocytic B cells in innate immunityJournal of Leukocyte Biology, 2012
- A Versatile and Tunable Coating Strategy Allows Control of Nanocrystal Delivery to Cell Types in the LiverBioconjugate Chemistry, 2011
- NanomedicineNew England Journal of Medicine, 2010
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based MechanismsMolecular Therapy, 2010
- Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) WarheadsJournal of the American Chemical Society, 2009
- “Re-educating” tumor-associated macrophages by targeting NF-κBThe Journal of Experimental Medicine, 2008
- Kupffer cells are central in the removal of nanoparticles from the organismParticle and Fibre Toxicology, 2007
- Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and ShapesNano Letters, 2007